TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
SinoMab Bioscience Ltd. ( (HK:3681) ) has issued an update.
SinoMab BioScience Limited announced a change in its company secretary position, with Ms. Chow Yuk Yin Ivy resigning and Ms. Lai Florence Wai Ki being appointed as her replacement, effective October 8, 2025. This transition is expected to strengthen the company’s corporate compliance and advisory capabilities, given Ms. Lai’s extensive experience and professional background.
The most recent analyst rating on (HK:3681) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on SinoMab Bioscience Ltd. stock, see the HK:3681 Stock Forecast page.
More about SinoMab Bioscience Ltd.
SinoMab BioScience Limited is a company incorporated in Hong Kong, operating within the biotechnology industry. The company focuses on the development of therapeutic products, particularly in the field of immunology.
Average Trading Volume: 19,863,366
Technical Sentiment Signal: Hold
Current Market Cap: HK$2.53B
See more insights into 3681 stock on TipRanks’ Stock Analysis page.